Cidara Therapeutics
CDTX
CDTX
58 hedge funds and large institutions have $119M invested in Cidara Therapeutics in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+7
Holders Change %
+13.73%
% of All Funds
1.45%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
13
Increased
26
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$5.15M |
| 2 |
BC
Broadfin Capital
New York
|
+$4.12M |
| 3 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$3.09M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.66M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.53M |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$240K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$229K |
| 3 |
SIM
Spark Investment Management
New York
|
-$172K |
| 4 |
TG
TLP Group
Evanston,
Illinois
|
-$62K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$33.7K |
